Get the Stockscreener App
43.02
2.58%
-1.1393
After Hours:
43.02
-0.0007
-0.00%
Tradr 2 X Long Innovation Etf stock is traded at $43.02, with a volume of 17,707.
It is down -2.58% in the last 24 hours and up +22.41% over the past month.
See More
Previous Close:
$44.16
Open:
$43.33
24h Volume:
17,707
Relative Volume:
0.41
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.83%
1M Performance:
+22.41%
6M Performance:
-31.68%
1Y Performance:
+10.88%
1-Day Range:
$41.85
$44.90
1-Week Range:
$38.43
$44.90
52-Week Range:
$18.25
$94.00
Tradr 2 X Long Innovation Etf Stock (TARK) Company Profile
Name
Tradr 2 X Long Innovation Etf
Sector
Industry
Phone
-
Address
-
Compare TARK vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TARK
Tradr 2 X Long Innovation Etf
|
43.02 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.00 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.31 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.46 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
271.12 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
608.91 | 124.43B | 0 | 0 | 0 | 0.00 |
Tradr 2 X Long Innovation Etf Stock (TARK) Latest News
Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Dan Herbatschek New York: Applied Mathematician and Technology Executive Continues to Shape Data-Driven Innovation - Barchart.com
Tradr 2X Long Innovation 100 Monthly ETF (MQQQ) Fundamental Analysis - Meyka
Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Cathie Wood Bought the Dip in Robinhood Stock. Should You Buy HOOD in February 2026 Too? - Barchart.com
Franklin Templeton Canada Announces ETF Cash Distributions - Barchart.com
Cathie Wood Is Selling Unity Software Stock Amid an ‘Apocalypse.’ Should You? - Barchart.com
Tradr Debuts Leveraged ETFs on Centrus Energy, CleanSpark and Coherent - IT-TIMES
Coherent Corp. to Host a Technology Innovation Briefing on March 17, 2026 - Barchart.com
Tofu Market Size to Reach USD 3.77 Billion by 2031 as Flexitarian Diets and Product Innovation Accelerate Growth - Barchart.com
Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% - Barchart.com
Tradr 2X Long Innovation ETF (TARK) ETF HoldersInstitutional Ownership - GuruFocus
Tradr 2X Long CLSK Daily ETF call volume above normal and directionally bullish - Yahoo Finance
As Cathie Wood Gobbles Up the Dip in Broadcom Stock, Should You Add AVGO Too? - Barchart.com
Innovative Industrial Properties Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Barchart.com
Bloom Energy, NuScale Power Buzz Drives ETF Action — Tradr Bets Double-Down Bear Plays - Benzinga
Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte, Novartis - Barchart.com
Fresh, Bold, Protein-Packed: Wendy's Introduces Two Savory Menu Innovations - Barchart.com
Breast Cancer Clinical Trial Pipeline Expands as 250+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
As Crypto Prices Plunge, Cathie Wood Is Selling This 1 Bitcoin Stock - Barchart.com
Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com
Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Resideo Wins Two 2026 IoT Breakthrough Awards for Smart Home Innovation - Barchart.com
Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson, Janssen Pharma, F. Hoffmann-La Roche., Merck - Barchart.com
Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com
Tradull’s Innovative Model: Enabling Individual Participation in Global Commodities Trade - Barchart.com
VenHub Wins RTIH Award for Most Innovative Retailer - Barchart.com
CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure - Barchart.com
Cathie Wood Keeps Buying Joby Aviation Stock. Should You? - Barchart.com
Lindemann & Partner Launches Innovative Platform for Certified Contract Terminations in Germany - Barchart.com
Clarivate Webinar "Intelligence Amplified in the Age of AI" Highlights How Trusted, Proprietary Data Powers Next‑Generation Innovation - Barchart.com
PayPal Appoints Enrique Lores as Chief Executive Officer and David W. Dorman as Independent Board Chair - Barchart.com
Playground Play Equipment Innovation Sets New Benchmark for Safe, Engaging Spaces, Says Golden Times - Barchart.com
Orbit Capital Announces Founder First Ecosystem Supporting 45 Companies - Barchart.com
Dr. Nitun Ahir Establishes New Academic Scholarship to Foster Innovation and Strategic Leadership in Modern Medicine - Barchart.com
Dr. Robert Corkern Award for Entrepreneurs Announces 2026 Application Cycle for Undergraduate Innovators - Barchart.com
Global RSV Vaccines Market Set to Reach US$1.24 Billion by 2030 - Barchart.com
Cognizant and Ace Hardware Celebrate 25 Years of Partnership to Advance Next-Generation E-Commerce and Supply Chain Innovation - Barchart.com
Cathie Wood Just Bet $26 Million on Broadcom Stock. Should You Buy AVGO Too? - Barchart.com
WhitelistVideo Named Best Parental Control for Innovative AI-Driven “Guardrail Discovery” Technology - Barchart.com
Belcan Government Solutions Secures SHIELD Contract to Deliver Innovative Defense Capabilities for Missile Defense Agency - Barchart.com
US ETF launches from 22nd to 29th January, 2026 - ETF Express
Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed - Barchart.com
Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Barchart.com
Tradr Debuts Leveraged ETFs on Lumentum, Sandisk and Western Digital - The AI Journal
New ETFs let traders double daily moves in LITE, SNDK, WDC - stocktitan.net
Sealed Air Celebrates Innovation and Its Iconic Brand on National Bubble Wrap® Appreciation Day - Barchart.com
Weekly ETF Industry News Recap | January 19-23, 2026 - Trackinsight
Tradr Launches 2x Short Leveraged ETFs on APLD, IREN, LCID and NBIS - FinanceFeeds
Cathie Wood Is Doubling Down on Broadcom Stock. Should You? - Barchart.com
Cathie Wood Is Betting Big on This 1 Mining Stock. What’s the Bull Case? - Barchart.com
Tradr 2 X Long Innovation Etf Stock (TARK) Financials Data
There is no financial data for Tradr 2 X Long Innovation Etf (TARK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.30%
0.06%
Cap:
|
Volume (24h):